Predictive analytics & biomarker discovery for cancer
Founded in 2015, bioSyntagma is a Startup Analytics and BI software company that provides predictive analytics & biomarker discovery for cancer to Healthcare companies.
This SaaS has a Local HQ located in Phoenix, and the company employs 1-10 employees who are led by David Richardson.
For more information, you can visit https://www.biosyntagma.com/.
David Richardson - CEO and Co-Founder, Dmitry Derkach MD, PhD - Chief Science Officer, Colleen Ziegler - Co-Founder, Director of Operations